Trending...
- Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago - 120
- Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations - 111
- $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
July 28, 2021
Contact: Chelsea Wuth, 517-241-2112
LANSING, Mich. - World Hepatitis Day is commemorated worldwide on July 28 to raise awareness of viral hepatitis, an inflammation of the liver that causes severe liver disease. There are five main strains of the hepatitis virus: A, B, C, D and E; however, hepatitis C is the most common hepatitis virus in the United States.
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), which can cause both acute (short-term) and chronic (long-term) illness. It is spread through contact with blood from an infected person. People with HCV infection are often undiagnosed because they remain asymptomatic until decades after infection when symptoms due to advanced liver disease manifest. There is no vaccine for HCV; however, there are effective medications that can cure HCV infection when taken once daily for eight to 12 weeks.
Last year, in recognition of World Hepatitis Day, the Michigan Department of Health and Human Services (MDHHS) announced the launch of the We Treat Hep C Initiative. This initiative is designed to eliminate hepatitis C in Michigan by increasing access to hepatitis C treatment among Michigan Medicaid and Healthy Michigan Plan beneficiaries.
More on Michimich.com
MDHHS has partnered with AbbVie, the manufacturer of the hepatitis C direct-acting antiviral MAVYRET®, to make the preferred product available to all Medicaid and Healthy Michigan Plan beneficiaries without prior authorization required. Since the removal of prior authorization from MAVYRET®, there has been a 56 percent increase in beneficiaries who have started HCV treatments.
"World Hepatitis Day is an additional opportunity to encourage all Michiganders to get tested for HCV at least one time in their life, and more frequently if they are in an at-risk category," said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health at MDHHS. "HCV is curable, and we are committed to making both testing and treatment accessible for all residents in need."
MDHHS has partnered with Wayne State University's Midwest AIDS Training and Education Center (WSU's MATEC) to provide case-based discussions, curricula and trainings for interested clinicians. In addition, MDHHS contracted with Henry Ford Health System to maintain an HCV clinical consultation line to provide peer-to-peer advice to clinicians in the process of evaluating and treating their patients for HCV (313-575-0332, Monday-Friday, 8 a.m. to 5 p.m., or online).
More on Michimich.com
Since the launch of the We Treat Hep C Initiative on April 1, WSU's MATEC and Henry Ford Health System have received 21 clinical consultations from providers across Michigan, disseminated resource packages with patient educational materials to health centers and clinics, developed webinar trainings and conducted presentations to various organizations and conferences. AbbVie has hosted seven statewide trainings, and over 100 clinicians and health care professionals have attended the trainings across Michigan.
MDHHS and its partners will continue to actively engage with stakeholders and clinicians to ensure Michiganders are linked to lifesaving hepatitis C testing, treatment and supportive services to help eliminate hepatitis C Michigan.
For more information, visit the We Treat Hep C webpage.
Contact: Chelsea Wuth, 517-241-2112
LANSING, Mich. - World Hepatitis Day is commemorated worldwide on July 28 to raise awareness of viral hepatitis, an inflammation of the liver that causes severe liver disease. There are five main strains of the hepatitis virus: A, B, C, D and E; however, hepatitis C is the most common hepatitis virus in the United States.
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), which can cause both acute (short-term) and chronic (long-term) illness. It is spread through contact with blood from an infected person. People with HCV infection are often undiagnosed because they remain asymptomatic until decades after infection when symptoms due to advanced liver disease manifest. There is no vaccine for HCV; however, there are effective medications that can cure HCV infection when taken once daily for eight to 12 weeks.
Last year, in recognition of World Hepatitis Day, the Michigan Department of Health and Human Services (MDHHS) announced the launch of the We Treat Hep C Initiative. This initiative is designed to eliminate hepatitis C in Michigan by increasing access to hepatitis C treatment among Michigan Medicaid and Healthy Michigan Plan beneficiaries.
More on Michimich.com
- Image Printing Company, Inc. Awarded GSA Multiple Award Schedule Contract, Expanding Federal Printing Capabilities
- Logicalis US Named to CRN's Tech Elite 250 for 2026
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
MDHHS has partnered with AbbVie, the manufacturer of the hepatitis C direct-acting antiviral MAVYRET®, to make the preferred product available to all Medicaid and Healthy Michigan Plan beneficiaries without prior authorization required. Since the removal of prior authorization from MAVYRET®, there has been a 56 percent increase in beneficiaries who have started HCV treatments.
"World Hepatitis Day is an additional opportunity to encourage all Michiganders to get tested for HCV at least one time in their life, and more frequently if they are in an at-risk category," said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health at MDHHS. "HCV is curable, and we are committed to making both testing and treatment accessible for all residents in need."
MDHHS has partnered with Wayne State University's Midwest AIDS Training and Education Center (WSU's MATEC) to provide case-based discussions, curricula and trainings for interested clinicians. In addition, MDHHS contracted with Henry Ford Health System to maintain an HCV clinical consultation line to provide peer-to-peer advice to clinicians in the process of evaluating and treating their patients for HCV (313-575-0332, Monday-Friday, 8 a.m. to 5 p.m., or online).
More on Michimich.com
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
- NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
- QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
Since the launch of the We Treat Hep C Initiative on April 1, WSU's MATEC and Henry Ford Health System have received 21 clinical consultations from providers across Michigan, disseminated resource packages with patient educational materials to health centers and clinics, developed webinar trainings and conducted presentations to various organizations and conferences. AbbVie has hosted seven statewide trainings, and over 100 clinicians and health care professionals have attended the trainings across Michigan.
MDHHS and its partners will continue to actively engage with stakeholders and clinicians to ensure Michiganders are linked to lifesaving hepatitis C testing, treatment and supportive services to help eliminate hepatitis C Michigan.
For more information, visit the We Treat Hep C webpage.
0 Comments
Latest on Michimich.com
- Hollywood's Elite Gather at the Annual WOW Creations Oscars Gifting Suite at the Universal Hilton
- Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
- Calmly Rooted Announces Strategic Evolution of "The Calm Collective" Wellness Hub
- JGCMGS Details Architecture to Safeguard Assets From Unauthorized Phishing Scams
- 21 Days: The Malta Deadline That Could Redraw the Finnish Online Casino Map
- JEGS Launches Modern, Secure Payments Powered by PhaseZero.ai
- U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
- New Report Reveals Surprising Trends in Ohio Airport Accidents
- Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
- WCC Kitchens and Cabinets Featured on Selling Houses Australia
- Cat Hunt Simulator : Burrow & Pounce Lands on the App Store
- Shincheonji Marks 42nd Anniversary: From a Basement to a Denomination Growing by Tens of Thousands Annually
- Jackets for Jobs Hosts Smart & Sexy® Day Detroit for Women's History Month
- Novi Custom Glass Manufacturer Explains When Foggy Windows Need to be Replaced
- Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
- $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
- High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
- Accelerating the Transformation into a U.S. Nuclear Fuel Cycle Leader: Frontier Nuclear and Minerals Inc. (N A S D A Q: FNUC)
- Ozz Metals Ltd Secures 1-Tonne Gold Offtake Agreement
- Jet Set: The Ultimate Coachella Afterparty